Treatment-Resistant Depression (TRD)
BrainsWay Deep TMS for patients who have not found relief through two or more antidepressant medication trials.
FDA-ClearedInsurance Covered
FDA-Cleared · Non-Drug · Non-Invasive
Advanced Deep TMS Therapy for Treatment-Resistant Depression in Bloomfield, NJ
FDA-cleared, non-drug, non-invasive neuromodulation led by Dr. Matthew Zuch and Dr. Ami Lim. Covered by major NJ insurance plans.
Bloomfield Ave, Bloomfield NJ · Serving Essex County and Northern New Jersey
For Patients
Seeking Relief from Depression or OCD?
Find out in 60 seconds whether BrainsWay Deep TMS could be right for you — no phone call required.
Start 60-Sec Eligibility ScreenerFor Doctors
Healthcare Provider Seeking Patient Referral?
A HIPAA-compliant portal for referring physicians, with weekly treatment progress reports.
Access B2B Physician PortalKey Clinical Services
BrainsWay Deep TMS uses magnetic coils to stimulate underactive brain regions — with zero systemic side effects or downtime.
MDD & Anxious Depression
Targeted treatment for Major Depressive Disorder and depression with co-occurring anxiety symptoms.
Non-InvasiveNo Downtime
OCD & Nicotine Addiction
FDA-cleared dTMS protocols for Obsessive-Compulsive Disorder and smoking cessation.
FDA-ClearedEvidence-Based
Founded by Clinicians, Not Marketers
Dr. Matthew Zuch
Former Clinical Director, NYU Langone Child Study Center NJ Campus
Brings academic-grade clinical rigor in child and adolescent psychiatry to interventional neuromodulation for adults and young people.
Dr. Ami Lim
Interventional Psychiatry Leader
Leads NeuroBoost's interventional psychiatry practice, pairing Deep TMS protocols with measurement-based care.
$7,200
Average gross practice revenue per completed 36-session Deep TMS protocol (CPT 90868 × 36). Capturing one extra patient inquiry per month pays for this platform many times over.